Das sieht nicht gut aus...........
Aktensplit
Calypte Biomedical Corporation Files Preliminary Proxy Statement
ALAMEDA, Calif.--Calypte Biomedical Corporation (OTCBB:CALY) today announced that it has filed a preliminary proxy statement with the Securities and Exchange Commission seeking stockholder approval to amend the Company`s Amended and Restated Certificate of Incorporation to implement a reverse split of the outstanding shares of Common Stock at the ratio of 1:30 to be effected immediately upon approval of the Company`s stockholders.
The Company said that the proposed reverse split, which has received the unanimous written consent of all Directors, is being implemented to enhance the Company`s long-term financing options. If approved, the proposed reverse stock split would reduce the presently issued and outstanding shares of Common Stock to approximately 8 million from approximately 236 million as of March 31, 2003.
Other proposals requiring stockholder approval include the election of eight directors to the Company`s Board, a proposed amendment to the 2000 Equity Incentive Plan, a proposed amendment to the 1995 Director Option Plan, a proposed amendment to the 1995 Employee Stock Purchase Plan and ratification of the appointment of KPMG LLP as independent auditors.
Stockholders of record on April 4, 2003 will be eligible to vote at the annual meeting, which is scheduled for 10:00 a.m. (Pacific), Tuesday, May 20, 2003 at the Company`s headquarters offices.
a reverse split of the outstanding shares of Common Stock at the ratio of 1:30 to be effected immediately upon approval of the Company`s stockholders.
Ich kaufe bei 0,015
Salut